Source: UNIVERSITY OF MICHIGAN submitted to
REGULATION OF THE CTS TYPE II SECRETION SYSTEM AND ITS ROLE IN GENETIC VARIATION OF CAMPYLOBACTOR JEJUNI
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
EXTENDED
Funding Source
Reporting Frequency
Annual
Accession No.
0220663
Grant No.
2010-65201-20594
Project No.
MICR-2009-03768
Proposal No.
2009-03768
Multistate No.
(N/A)
Program Code
93231
Project Start Date
Feb 1, 2010
Project End Date
Jun 30, 2012
Grant Year
2010
Project Director
Johnson, J.
Recipient Organization
UNIVERSITY OF MICHIGAN
(N/A)
ANN ARBOR,MI 48109
Performing Department
Unit for Laboratory Animal Medicine
Non Technical Summary
The bacterium Campylobacter jejuni is a leading cause of foodborne illness in humans. C. jejuni is commonly found in the chicken gastrointestinal tract, but does not cause disease. Infection by C. jejuni is typically caused by the ingestion of contaminated food and water sources. Campylobacter typically causes inflammatory diarrhea, but can manifest itself in more severe forms of disease. The spread of antibiotic resistance is an increasing concern in many bacterial species. Natural competence is one mechanism for the genetic transfer of both antibiotic resistance and virulence factors among bacteria. The goal of this project is to address genetic exchange and regulation, strain variation, and antibiotic resistance in the naturally competent bacterium Campylobacter jejuni. This project will identify factors important for the uptake and integration of extracellular DNA into the Campylobacter chromosome. A multiprotein system, called the Cts system, controls natural competence in C. jejuni, but the exact mechanism of action remains unclear at this time. Additionally, conditions in which natural competence is induced are not entirely understood. This proposal is designed to close gaps in our understanding of the mechanism and timing of Cts function.
Animal Health Component
(N/A)
Research Effort Categories
Basic
90%
Applied
10%
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
71240101100100%
Goals / Objectives
Specific Aim 1. Analyze the roles of the Cts and pVir encoded transformation systems during chick colonization. Using in vitro and in vivo transformation experiments, I will test the contributions to transformation of two different systems suggested to have roles in C. jejuni natural competence, the Cts and pVir systems. I will develop an in vivo co-culture model that will test mutations for colonization of the chick and transformation efficiencies in this model. Specific Aim 2. Determine the cis- and trans-regulatory elements of the cts genes. Using an astA reporter fusion to the transformation system gene, ctsX, and transposon mutagenesis, I will identify regulatory elements of the cts genes. I will develop a selectable IVET system to study cts gene regulation in vivo. Specific Aim 3. Role CtsX in natural transformation. I will identify proteins interacting with the membrane bound CtsX using crosslinking and co-immunoprecipitation experiments. I will construct mutant forms of CtsX to determine important domains for function of CtsX in natural transformation and interaction with other proteins identified during crosslinking and co-immunoprecipitation experiments.
Project Methods
Traditional and emerging molecular biology techniques will be used to study the role of the Cts system in natural competence of Campylobacter. I will use the day-of-hatch chick model of Campylobacter infection to study natural transformation in vivo. Day-of-hatch chicks will be infected by oral gavage with streptomycin resistant DRH212 and 81-176 astA::cat. After seven days, I will sacrifice the chicks, harvest organs, and plate on non-selective media to obtain total amount of C. jejuni in the chick. Then, I will replica plate to screen for colonies that are chloramphenicol and streptomycin resistant, indicating the transformation of DNA between strains. In vitro transformation experiments are performed by adding purified DNA, carrying chloramphenicol resistance, to C. jejuni cells and then plating as described for the in vivo experiments. Traditional genetic approaches using reporter gene fusions and transposon mutagenesis will be used to identify regulators of the Cts system. I constructed an astA fusion to ctsX and will identify transcriptional regulators of the cts genes using this fusion. To do this, a transposon mutagenesis procedure previously described in this lab will be performed and colonies will be screened for changes in colony color on MH plates containing XS. Colonies with an increased level of blue color indicate an increase in ctsX expression and suggest that a repressor of cts expression has been disrupted. White colonies indicate that expression of ctsX has been lowered and suggest that an activator of cts has been disrupted. Once insertions altering the expression of cts have been isolated, the location of the insert will be identified by inverse PCR and semi-exponential cycle sequencing. The resulting DNA sequence will be compared to the C. jejuni 81-176 genome sequence. Finally, a resolvase-reporter system (selectable IVET) will be developed to study expression of cts genes during chicken colonization. This will be modified from an existing system used in E. coli to work in C. jejuni. This will also be applied more broadly to identify promoters activated by C. jejuni during growth in the chicken gastrointestinal tract. Co-immunoprecipation experiments will be carried out to identify proteins with which CtsX interacts. A CtsX-FLAG tagged protein has been made and is being used in these experiments. I will obtain a whole cell lysate under non-denaturing conditions to maintain protein-protein interactions. Using antibodies to the FLAG epitope tag, I will purify CtsX-FLAG and, presumably, any other protein associated with it. I will run the resulting protein complex on an acrylamide gel and stain to observe potential bands in the elution fractions. Finally, I will identify proteins associating with CtsX by MALDI-TOF analysis.

Progress 02/01/10 to 01/31/12

Outputs
OUTPUTS: I succeeded Dr. Jeremy Ellermeier in this project on July 25, 2011. Since that time I have spent approximately 80% of my time working on experiments to determine whether DNA damage induces competence in Campylobacter jejuni and developing a mutagenesis system novel to C. jejuni, which will contribute to these and other Campylobacter studies I am doing. Another 15% of my time was dedicated to training an undergraduate student through the University of Michigan Undergraduate Research Opportunities Program. Lastly, I dedicated the remaining 5% of my time to attendance at departmental and institutional seminars and laboratory meetings. I was also fortunate in that I was afforded the opportunity to present some of my earliest work in the DiRita Laboratory at the 18th Annual Midwest Microbial Pathogenesis Conference in Ann Arbor, MI in October 2011. PARTICIPANTS: Jeremiah Johnson Elizabeth Del Cimmuto. Undergraduate student, University of Michigan (she is no longer working in the DiRita Laboratory.) Jessica Beauchamp. Graduate Student, Department of Microbiology & Immunology, University of Michigan (working on Ph.D. thesis in the DiRita laboratory extending the Cts studies) TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: We determined it is appropriate to continue exploring the role of Cts genes in Campylobacter biology and this will be the thesis topic of Ms. Beauchamp. To gain a deeper understanding of the biology of competence we have developed a mutagenesis system that we can apply to identify mutants unable to take up DNA under specific conditions, which will expand the work into a broad genetic analysis of competence regulation.

Impacts
I examined whether DNA damage could induce natural competence/DNA uptake in C. jejuni. There is precedence for this as a similar mechanism has been observed for Helicobacter pylori competence. The group that made this initial finding used the DNA gyrase inhibitor ciprofloxacin to induce DNA double-strand breaks in the chromosome of H. pylori and then examined for DNA uptake in response to this damage. Using a similar approach, I identified the minimum inhibitory concentration of ciprofloxacin for C. jejuni and subsequently examined for transformation efficiency in media supplemented with or without the antibiotic. I discovered that ciprofloxacin did not alter the transformation efficiency of a plasmid containing an marker into C. jejuni. This was confirmed with two repetitions of the experiment. From this, we conclude that inducing DNA damage in C. jejuni does not result in a noticeable increase in DNA uptake as is seen in H. pylori. A second project I worked on was centered on the development of a transposon-based mutagenesis procedure for C. jejuni that would allow for the use of INSeq (Tn-seq) technology to identify factors of interest. To expand our research into a genetic approach for identifying competence/DNA uptake regulators, I developed a mariner transposon derivative that incorporates features necessary to carry out a deep-sequence-based mutagenesis screen called InSeq. I mutagenized genomic DNA of wild-type C. jejuni and demonstrated by Southern blotting that the transposon inserts at high frequency and randomly. I then extended this mutagenesis and and collected approximately 8500 individual C. jejuni mutants, which represents 5x coverage of the genome. These mutants have been stored in a 96-well format, which will allow for construction of an ordered library via INSeq-based combinatorial pooling. This mutant population will be subjected to several selections to identify genes required for host cell invasion, chicken colonization, DNA uptake/competence, etc. We will array this library in such a way to identify any particular mutant based on its locus tag from the stored library - as such this will be an invaluable tool for the field, and we will readily share it.

Publications

  • No publications reported this period